Paris, France

Eric Beusoleil


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eric Beusoleil

Introduction

Eric Beusoleil is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with analgesic and immunostimulant properties. With a total of three patents to his name, Beusoleil's work has the potential to impact medical treatments significantly.

Latest Patents

Beusoleil's latest patents include innovative compounds such as 1-aryl-1-hydroxy-2,3-diamino-propyl amines and 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines. These compounds are defined by specific formulas where the variables have particular meanings as outlined in the specifications. They exhibit analgesic and/or immunostimulant effects in mammals, showcasing their potential therapeutic applications.

Career Highlights

Throughout his career, Eric Beusoleil has worked with prominent companies in the pharmaceutical industry, including Allergan, Inc. and Exonhit Therapeutics. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research and development in his field.

Collaborations

Beusoleil has collaborated with esteemed colleagues such as Bertrand Leblond and Thierry Taverne. These partnerships have likely enhanced his research efforts and contributed to the successful development of his patented compounds.

Conclusion

Eric Beusoleil's innovative work in the pharmaceutical sector, particularly with his patented compounds, highlights his significant contributions to medical science. His collaborations and career experiences further underscore his role as a leading inventor in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…